Solventum Corporation

SOLV · Healthcare

$90.95

Capitalización: 15.48B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Solventum Corporation? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Zacks Investment Research2 sept 2026, 13:30

Earnings Growth & Price Strength Make Solventum (SOLV) a Stock to Watch

Solventum Corporation (SOLV), a healthcare company spun off from 3M, has been added to the Zacks Focus List. The stock has gained 31.53% since its April 2024 IPO at $69.15, now trading at $90.95. Six analysts raised earnings estimates in the last 60 days, with consensus estimates increasing $0.55 to $7.13 for fiscal 2026. The company is expected to deliver 16.7% earnings growth for the current fiscal year and has demonstrated a 13.2% average earnings surprise.